Status Quo of Cost Estimation and Systematic Review in Pharmacy Intravenous Admixture Services in China
- VernacularTitle:我国静脉用药集中调配中心成本测算现状及系统评价
- Author:
Chunsong YANG
1
,
2
;
Tianyi ZHANG
3
;
Lingli ZHANG
1
,
2
;
Yunzhu LIN
1
,
2
;
Lu HAN
1
,
2
;
Yeli WANG
1
,
2
;
Shan GAO
1
,
2
;
Wenrong JIN
1
Author Information
1. Dept. of Pharmacy/Evidence-based Pharmacy Center，West China Second Hospital，Sichuan University，Chengdu 610041，China
2. Key Laboratory of Birth Defects and Related Diseases of Women and Children，Sichuan University，Ministry of Education，Chengdu 610041，China
3. West China School of Pharmacy，Sichuan Uni versity
- Publication Type:Journal Article
- Keywords:
Pharmacy intravenous admixture services;
Cost estimation;
Status quo;
Influential factor;
Systematic review
- From:
China Pharmacy
2019;30(19):2707-2711
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE： To systematically evaluate the status quo of cost estimation in pharmacy intravenous admixture services （PIVAS）， and to provide cost basis for the construction of PIVAS in China. METHODS： Retrieved from PubMed， Embase， Cochrane library， CBM， CNKI， CSJD and Wanfang database from database establishment to Jan. 2019， the studies about the status quo of cost estimation in PIVAS of China were included. The descriptive analysis was conducted for content and method of cost estimation， infection to hospital. RESULTS： A total of 17 literatures were included， involving 8 before and after control studies， 6 experience sharing studies and 3 reviews. Existing reports showed that the estimation contents and methods of PIVAS cost were roughly the same. The cost included manpower， medical and health materials， fixed asset purchase， depreciation， repair costs， medicine cost and indirect costs. At the same time， the infection to hospital were reported， such as in manpower adopting， formulating detailed management measures and systems， concurrent allocation of the same kind of drugs， shortening infusion preparation and replacement time， in order to save manpower cost. CONCLUSIONS： PIVAS cost calculation method is roughly the same in some hospitals， but there is no uniform standard. It is necessary to further improve the PIVAS cost measurement standard and provide a basis for the construction and development of PIVAS in China.
